Chitosan Nanoparticles for Prolonged Delivery of Timolol Maleate

REFERENCES

• Aggarwal D., Kaur I. P. Improved pharmacodynamics of timolol maleate from a mucoadhesive niosomal ophthalmic drug delivery system. International Journal of Pharmaceutics 2005; 290: 155–159
   PubMed Web of Science ®Google Scholar
• Agnihotri S. A., Aminabhavi T. M. Controlled release of clozapine through chitosan microparticles prepared by a novel method. Journal of Controlled Release 2004b; 96: 245–259
   PubMed Web of Science ®Google Scholar
• Agnihotri S. A., Mallikarjuna N. N., Aminabhavi T. M. Recent advances on chitosan-based micro and nanoparticles in drug delivery. Journal of Controlled Release 2004a; 100: 5–28
   PubMed Web of Science ®Google Scholar
• Aminabhavi T. M., Agnihotri S. A., Naidu B. V. K. Rheological studies on stimuli responsive gel forming polymeric solutions for ophthalmic applications and their drug release characteristics. Journal of Applied Polymer Science 2004; 94: 2057–2064
   Web of Science ®Google Scholar
• Artursson P., Lindmark T., Davis S. S., Illum L. Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2). Pharmaceutical Research 1994; 11: 1358–1361
   PubMed Web of Science ®Google Scholar
• Bourlais C. L., Acar L., Zia H., Sado P. A., Needham T., Leverge R. Ophthalmic drug delivery systems-recent advances. Progress in Retinal and Eye Research 1998; 17: 33–58
   PubMed Web of Science ®Google Scholar
• Calvo P., Vila-Jato J. L., Alonso M. J. Evaluation of cationic polymer-coated nanocapsules as ocular drug carriers. International Journal of Pharmaceutics 1997; 153: 41–50
   Web of Science ®Google Scholar
• De Campos A. M., Sanchez A., Alonso M. J. Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A. International Journal of Pharmaceutics 2001; 224: 159–168
   PubMed Web of Science ®Google Scholar
• De Campos A. M., Sanchez A., Gref R., Calvo P., Alonso M. J. The effect of a PEG versus a chitosan coating on the interaction of drug colloidal carriers with the ocular mucosa. European Journal of Pharmaceutical Science 2003; 20: 73–81
   PubMed Web of Science ®Google Scholar
• Di Colo G., Zambito Y., Burgalassi S., Serafini A., Saettone M.F. Effect of chitosan on in vitro release and ocular delivery of ofloxacin from erodible inserts based on poly(ethylene oxide). International Journal of Pharmaceutics 2002; 248: 115–122
   PubMed Web of Science ®Google Scholar
• El-Kamel A. H. In vitro and in vivo evaluation of Pluronic F127-based ocular delivery system for timolol maleate. International Journal of Pharmaceutics 2002; 241: 47–55
   PubMed Web of Science ®Google Scholar
• Felt O., Furrer P., Mayer J. M., Plazonnet B., Buri P., Gurny R. Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retention. International Journal of Pharmaceutics 1999; 180: 185–193
   PubMed Web of Science ®Google Scholar
• Genta I., Conti B., Perugini P., Pavaneto F., Spadaro A., Puglisi G. Bioadhesive microspheres for ophthalmic administration of acyclovir. Journal of Pharmacy and Pharmacology 1997; 49: 737–742
   PubMed Web of Science ®Google Scholar
• Grzeskowiak E. Biopharmaceutical availability of sulphadicramide from ocular ointments in vitro. European Journal of Pharmaceutical Science 1998; 6: 247–53
   PubMed Web of Science ®Google Scholar
• Hornof M., Weyenberg W., Ludwig A., Bernkop-Schnurch A. Mucoadhesive ocular insert based on thiolated poly(acrylic acid): development and in vivo evaluation in humans. Journal of Controlled Release 2003; 89: 419–428
   PubMed Web of Science ®Google Scholar
• Jarho P., Jarvinen K., Urtti A., Stella V. J., Jarvinen T. Modified beta-cyclodextrin (SBE7-beta-CyD) with viscous vehicle improves the ocular delivery and tolerability of pilocarpine prodrug in rabbits. Journal of Pharmacy and Pharmacology 1996; 48: 263–269
   PubMed Web of Science ®Google Scholar
• Kaur I. P., Garg A., Singla A. K., Aggarwal D. Vesicular systems in ocular drug delivery: an overview. International Journal of Pharmaceutics 2004; 269: 1–14
   PubMed Web of Science ®Google Scholar
• Kaur I. P., Kanwar M. Ocular preparations: The formulation approach. Drug Development and Industrial Pharmacy 2002; 28: 473–493
   PubMed Web of Science ®Google Scholar
• Ke T. L., Cagle G., Schlech B., Lorenzetti O. J., Mattern J. Ocular bioavailability of ciprofloxacin in sustained release formulations. Journal of Ocular Pharmacology and Therapeutics 2001; 17: 555–563
   PubMed Web of Science ®Google Scholar
• Knapczyk J., Krowczynski L., Krzck J., Brzeski M., Nirnberg E., Schenk D., Struszcyk H. Requirements of chitosan for pharmaceutical and biomedical applications. Chitin and chitosan: Sources, chemistry, biochemistry, physical properties, and applications, G. Skak-Braek, T. Anthonsen, P. Sandford. Elsevier, London 1989; 657–663
   Google Scholar
• Li V. H., Robinson J. R. Solution viscosity effects on the ocular disposition of cromolyn sodium in the albino rabbit. International Journal of Pharmaceutics 1989; 53: 219–225
   Web of Science ®Google Scholar
• Marchal-Heussler I., Maincent P., Hoffman M., Spittler J., Couvreur P. Antiglaucomatous activity of betaxolol chlorhydrate sorbed onto different isobutyl cyanoacrylate nanoparticle preparations. International Journal of Pharmaceutics 1990; 58: 115–122
   Web of Science ®Google Scholar
• Mendenhall W., Sincich T. Multiple regression. A second course in business statistics: regression analysis3rd. Dellen Publishing, California 1989; 141–226
   Google Scholar
• Okhamafe A. O., Goosen M. F. A. Control of membrane permeability in microcapsules. Fundamentals of animal cell encapsulation and immobilization, M. F. A. Goosen. CRC Press, Boca Raton, Florida 1993; 55–78
   Google Scholar
• Ravi Kumar M. N. V. A review of chitin and chitosan applications. Reactive and Functional Polymers 2001; 46: 1–27
   Web of Science ®Google Scholar
• Ritger P. L., Peppas N. A. A simple equation for description of solute release. II. Fickian and anomalous release from swellable devices. Journal of Controlled Release 1987; 5: 37–42
   Google Scholar
• Rozier A., Mazuel C., Grove J., Plazonnet B. Gelrite®: A novel, ion-activated, in situ gelling polymer for ophthalmic vehicles. Effect on bioavailability of timolol. International Journal of Pharmaceutics 1989; 57: 163–168
   Web of Science ®Google Scholar
• Schoenwald R. D., Stewart P. Effect of particle size on ophthalmic bioavailability of dexamethasone suspensions in rabbit. Journal of Pharmaceutical Sciences 1980; 69: 391–393
   PubMed Web of Science ®Google Scholar
• Thermes F., Rozier A., Plazonnet B., Grove J. Bioadhesion: The effect of polyacrylic acid on the ocular bioavailability of timolol. International Journal of Pharmaceutics 1992; 81: 59–65
   Web of Science ®Google Scholar
• Uusitalo H., Kahonen M., Ropo A., Turjanmaa V. The evaluation of efficacy and systemic side effects of topical antiglaucoma drugs: the benefits of improved drug formulation. Journal of Glaucoma 1999; 8: 264–265
   Google Scholar
• Vega E., Egea M. A., Valls O., Espina M., Garcia M. L. Flurbiprofen loaded biodegradable nanoparticles for ophtalmic administration. Journal of Pharmaceutical Sciences 2006; 95: 2393–2405
   PubMed Web of Science ®Google Scholar
• Wolfhagen F. H. J., Groen F. C., Ouwendijk R. J. Severe nausea and vomiting with timolol eye drops. Lancet 1998; 352: 373
   PubMed Web of Science ®Google Scholar
• Zimmer A. K., Zerbe H., Kreuter J. Evaluation of pilocarpine-loaded albumin particles as drug delivery systems for controlled delivery in the eye I. In vitro and in vivo characterization. Journal of Controlled Release 1994; 32: 57–70
   Web of Science ®Google Scholar